Weekly Insulin Becoming a Reality

Affiliations

Comment

Jay S Skyler. Diabetes Care. 2021 Jul.

. 2021 Jul;44(7):1459-1461.

doi: 10.2337/dci21-0011. Epub 2021 Jun 21.

¹ Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL jskyler@miami.edu.

No abstract available

Comment on

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100.
Lingvay I, Buse JB, Franek E, Hansen MV, Koefoed MM, Mathieu C, Pettus J, Stachlewska K, Rosenstock J. Lingvay I, et al. Diabetes Care. 2021 Jul;44(7):1595-1603. doi: 10.2337/dc20-2878. Epub 2021 Apr 19. Diabetes Care. 2021. PMID: 33875484 Free PMC article. Clinical Trial.
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Bajaj HS, Bergenstal RM, Christoffersen A, Davies MJ, Gowda A, Isendahl J, Lingvay I, Senior PA, Silver RJ, Trevisan R, Rosenstock J. Bajaj HS, et al. Diabetes Care. 2021 Jul;44(7):1586-1594. doi: 10.2337/dc20-2877. Epub 2021 Apr 19. Diabetes Care. 2021. PMID: 33875485 Free PMC article. Clinical Trial.